A new Periodic Transaction Report filed with the U.S. House of Representatives shows Hon. April McClain Delaney disclosing another sale of Service Corporation International (SCI) stock, this time made on behalf of her dependent child. The transaction, dated July 27, 2026, falls in the disclosed range of $1,001 to $15,000, a bracket commonly used under the STOCK Act to report modest holdings without specifying exact dollar amounts.
This is not an isolated filing. It follows a string of recent SCI sales tied to the same dependent account, including one covered in our earlier report, April McClain Delaney’s Dependent Sells More SCI Stock, which detailed a similar transaction just days earlier. Taken together, these filings point to an ongoing pattern of incremental SCI stock sales from the same dependent-held position rather than a single, isolated trade.
An Insider Sale Adds Context
What makes this latest disclosure notable is its proximity to activity inside the company itself. Corporate insider Faulk John H sold SCI shares on July 31, 2026, in a transaction valued at $1,048,698 — a sale that occurred within 30 days of the congressional filing. While the two transactions are unrelated in terms of who filed them and under what legal framework, the timing places both a member of Congress’s dependent and a company insider on the same side of the market for SCI stock within a short window.
It’s worth being clear about what this does and doesn’t mean. STOCK Act disclosures exist precisely so that the public can see when members of Congress or their immediate family hold or trade individual stocks. Filing this report is a legal obligation, not an indication of wrongdoing, and insider sales by corporate executives are similarly routine and often tied to pre-scheduled trading plans, compensation events, or personal financial planning unrelated to any nonpublic information. Neither the size of the disclosed range nor the timing relative to the insider sale is, on its own, evidence of coordination or misconduct.
Still, the overlap is the kind of data point that trackers like this one exist to surface. A dependent-held SCI position has now shown multiple sales in a short span, and a company insider parted with a seven-figure stake in the same stock less than a week later. Whether these are simply two unconnected financial decisions happening to land close together, or part of a broader pattern worth continued monitoring, is something future filings may help clarify. For now, the public record shows both transactions exactly as disclosed, with no additional detail available about the reasoning behind either sale.